Abiopharma

KALA BIO Settles Approximately $10.6 million of Debt

Vir Biotechnology - Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference

The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience

Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)